Style de citation APA (7e éd.)

G, W., J, Z., M, Z., Q, W., B, C., Y, H., & K, L. (2019). Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFRL858R/T790M mutation. Dove Medical Press.

Style de citation Chicago (17e éd.)

G, Wang, Zhao J, Zhang M, Wang Q, Chen B, Hou Y, et Lu K. Ferumoxytol and CpG Oligodeoxynucleotide 2395 Synergistically Enhance Antitumor Activity of Macrophages Against NSCLC with EGFRL858R/T790M mutation. Dove Medical Press, 2019.

Style de citation MLA (8e éd.)

G, Wang, et al. Ferumoxytol and CpG Oligodeoxynucleotide 2395 Synergistically Enhance Antitumor Activity of Macrophages Against NSCLC with EGFRL858R/T790M mutation. Dove Medical Press, 2019.